Grifols SA (GRFS)
Grifols Market Cap : 6.240B for Feb. 11, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Biodexa Pharmaceuticals Plc | 1.015M |
| Akari Therapeutics Plc | 9.221M |
| Pharma Mar SA | 1.523B |
| Autolus Therapeutics Plc | 372.60M |
| Oryzon Genomics SA | 283.87M |
Market Cap Related Metrics
| PE Ratio | 14.93 |
| PS Ratio | 0.7504 |
| PEG Ratio | 0.0899 |
| Price to Book Value | 2.708 |
| Price to Free Cash Flow | 8.049 |
| Price | 9.17 |
| Earnings Yield | 6.70% |
| PEGY Ratio | 0.0889 |
| Operating PE Ratio | 4.149 |
| Normalized PE Ratio | 15.71 |